Stephen Beard Sells 3,545 Shares of Adtalem Global Education (NYSE:CVSA) Stock

Adtalem Global Education Inc. (NYSE:CVSA) CEO Stephen Beard sold 3,545 shares of the stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $130.34, for a total value of $462,055.30. Following the transaction, the chief executive officer directly owned 415,197 shares in the company, valued at $54,116,776.98. The trade was a 0.85% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Trading Up 0.1%

Shares of Adtalem Global Education stock opened at $131.98 on Friday. The stock has a market capitalization of $4.49 billion, a price-to-earnings ratio of 18.75, a P/E/G ratio of 0.98 and a beta of 0.62. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.09 and a current ratio of 1.09. Adtalem Global Education Inc. has a 12 month low of $86.97 and a 12 month high of $156.26. The company’s fifty day moving average price is $125.26.

Adtalem Global Education (NYSE:CVSA) last released its quarterly earnings data on Thursday, August 6th. The company reported $2.09 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.19. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%.The firm had revenue of $501.38 million during the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. Analysts forecast that Adtalem Global Education Inc. will post 8.99 earnings per share for the current year.

Institutional Trading of Adtalem Global Education

A hedge fund recently bought a new stake in Adtalem Global Education stock. Kendall Capital Management bought a new position in shares of Adtalem Global Education Inc. (NYSE:CVSA) during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund bought 11,622 shares of the company’s stock, valued at approximately $1,449,000. 98.84% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on CVSA shares. Wall Street Zen upgraded shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Truist Financial boosted their price objective on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday, May 11th. Barrington Research reaffirmed an “outperform” rating and set a $170.00 target price on shares of Adtalem Global Education in a research report on Monday, June 8th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Adtalem Global Education in a research report on Friday, May 22nd. Two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $155.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.